List of insiders holdings for KalVista Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
2025-04-11 17:22:07 | 0 5,303,985 |
5,303,985 | Form 4 |
| 2 | InterWest Management Partners IX LLC InterWest Partners IX LP GIANOS PHILIP T ORONSKY ARNOLD L Kliman Gilbert H Holmes W Stephen Kjellson Nina S Pepper Douglas A CLEVELAND BRUCE A NASR KHALED 10% Owner |
2016-06-23 17:29:03 | 4,619,195 0 |
4,619,195 | Form 13D |
| 3 | NOHRA GUY P Director |
2015-04-14 17:22:50 | 0 4,343,550 |
4,343,550 | Form 4 |
| 4 | ACMP IV LLC ACP IV L.P. JANNEY DANIEL 10% Owner |
2016-06-24 16:16:50 | 4,343,550 0 |
4,343,550 | Form 13D |
| 5 | Shah Rajeev M. Director 10% Owner |
2017-10-16 16:31:07 | 0 1,441,070 |
1,441,070 | Form 4 |
| 6 | Vivo Ventures VI LLC Vivo Ventures Fund VI L.P. VIVO VENTURES VI AFFIILATES FUND L.P. 10% Owner |
2022-02-11 17:28:19 | 1,383,179 0 |
1,383,179 | Form 13G |
| 7 | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
2020-02-14 16:07:48 | 986,173 0 |
986,173 | Form 13G |
| 8 | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER |
2025-03-10 18:43:21 | 475,312 0 |
475,312 | Form 4 |
| 9 | Crockett Thomas Andrew CEO |
2024-02-21 21:41:48 | 395,394 0 |
395,394 | Form 4 |
| 10 | Audhya Paul K. CHIEF MEDICAL OFFICER |
2025-02-25 20:37:22 | 267,940 0 |
267,940 | Form 4 |
| 11 | Yea Christopher CHIEF DEVELOPMENT OFFICER |
2025-02-25 20:36:14 | 194,577 0 |
194,577 | Form 4 |
| 12 | Feener Edward P. CHIEF SCIENTIFIC OFFICER |
2024-05-21 17:59:02 | 116,214 0 |
116,214 | Form 4 |
| 13 | White Thomas Michael See Remarks |
2015-04-08 21:19:26 | 105,506 0 |
105,506 | Form 3 |
| 14 | Gravett David M. VP, Research & Development |
2016-01-05 16:07:23 | 100,000 0 |
100,000 | Form 4 |
| 15 | Piekos Brian Chief Financial Officer |
2025-02-25 20:35:13 | 80,000 0 |
80,000 | Form 4 |
| 16 | Ramiya Premchandran Vice President of Supply Chain |
2016-01-05 16:05:25 | 60,586 0 |
60,586 | Form 4 |
| 17 | Saul David Joseph Director |
2016-02-02 17:06:31 | 56,000 0 |
56,000 | Form 4 |
| 18 | Lewis Hayley See Remarks |
2015-08-05 16:26:10 | 33,181 0 |
33,181 | Form 4 |
| 19 | Katkin Keith Director |
2015-08-05 16:28:56 | 29,000 0 |
29,000 | Form 4 |
| 20 | Clapper David M Director |
2015-08-05 16:30:42 | 29,000 0 |
29,000 | Form 4 |
| 21 | Smith Michael David Senior VP, Development |
2022-05-19 16:59:11 | 25,800 0 |
25,800 | Form 4 |
| 22 | Maetzel Andreas Senior Vice President, Medical |
2021-05-28 17:20:55 | 25,000 0 |
25,000 | Form 4 |
| 23 | Reid Laurence Director |
2024-11-26 16:41:52 | 17,000 0 |
17,000 | Form 4 |
| 24 | Zadno Reza Director |
2015-08-05 16:25:24 | 15,750 0 |
15,750 | Form 4 |
| 25 | SOLAND DANIEL B Director |
2021-10-01 16:56:56 | 10,000 0 |
10,000 | Form 4 |
| 26 | Edwards Martin Director |
2021-10-04 16:53:55 | 10,000 0 |
10,000 | Form 4 |
| 27 | Cha Albert Director |
2023-09-28 16:52:27 | 10,000 0 |
10,000 | Form 4 |
| 28 | McKune John See Remarks |
2016-01-05 16:05:25 | 10,000 0 |
10,000 | Form 4 |
| 29 | Unkart Edward W Director |
2024-10-04 16:06:15 | 10,000 0 |
10,000 | Form 4 |
| 30 | Treanor Patrick Director |
2024-10-04 16:07:02 | 10,000 0 |
10,000 | Form 4 |
| 31 | Stuart Nancy Director |
2024-10-04 16:07:41 | 10,000 0 |
10,000 | Form 4 |
| 32 | Pereira Brian JG Director |
2024-10-04 16:08:14 | 10,000 0 |
10,000 | Form 4 |
| 33 | Fairey William Director |
2024-10-04 16:08:45 | 10,000 0 |
10,000 | Form 4 |
| 34 | ORONSKY ARNOLD L Director |
2020-10-02 20:35:13 | 7,000 0 |
7,000 | Form 4 |
| 35 | ALDRICH RICHARD Director |
2018-10-05 18:03:47 | 7,000 0 |
7,000 | Form 4 |
| 36 | Resnick Joshua Director |
2017-09-29 20:17:42 | 6,000 0 |
6,000 | Form 4 |
| 37 | Maroney Marcee VP, Clinical Affairs |
2016-11-22 16:13:38 | 0 0 |
0 | Form 4 |
| 38 | Basta Steven L Director |
2016-11-22 16:14:38 | 0 0 |
0 | Form 4 |
| 39 | RA CAPITAL MANAGEMENT LLC RA Capital Healthcare Fund LP Kolchinsky Peter Director |
2022-08-15 17:12:46 | 0 0 |
0 | Form 13G |
| 40 | Renzi David President & CEO |
2016-11-23 13:35:03 | 0 0 |
0 | Form 4 |
| 41 | Novo Holdings A/S 10% Owner |
2017-10-13 16:56:03 | 0 0 |
0 | Form 13D |
| 42 | RA CAPITAL MANAGEMENT LLC Kolchinsky Peter Director 10% Owner |
2022-08-15 17:12:46 | 0 0 |
0 | Form 13G |
| 43 | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
2021-02-16 16:03:37 | 0 0 |
0 | Form 13D |